The fact that CORT and diverse NK1 receptor antagonists are currently in various stages of clinical trials concerned with the treatment of anxiety disorders [28], [31], [77], [78] underlines a potential translational value to the present results in HAB mice. This evidence concerns the gene CORT and anxiety disorder.